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delivery. This has been attributed to the direction of the
expulsive force toward the perineal body and delivery of a
larger diameter caused by a deflexed head [2].
With occipitoanterior deliveries themechanism is different,
but in both types of delivery the tear is caused when the fetal
head is directed posteriorly. With occipitoanterior deliveries
this may be caused by an anatomical variation of the pelvis or a
large fetal head. In the present case the neonate was larger
than average, but we also noted that the perineal body was
longer than usual. The combination of these factors may have
directed the expulsive forces posterior to the introitus. The
fetal head subsequently split the posterior vaginal wall and
rectovaginal septum from the perineal body and came into
direct contact with the muscles of the perineal body, tearing
them with subsequent pushing. Of note, this did not happen
when the woman was pushing in the hands and knees position;
this is because gravitational forces cause the fetal head to fall
away from the posterior pelvis. In the present case a
combination of these factorsmayhave caused this unusual tear.
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Small for gestational age
Celiac disease is a genetically-determined permanent intol-
erance to gluten. Untreated disease can result in a varying
degree of intestinal villous atrophy and malabsorption. The
prevalence is between 0.3% and 1.2%, with a high percentage
(about 60%) of subclinical cases [1]. Some studies suggest
that even in subclinical cases, malnutrition and vitamin
deficiency during pregnancy could result in fetal growth
restriction or pre-eclampsia.
To test this hypothesis we performed a case-control study of
women who delivered at the Academic Medical Center,
Amsterdam, between 1993 and 2004. The study was approved
by the medical ethical committee of our hospital. Inclusion
criteria were white nulliparous women with a singleton
pregnancy who delivered a small for gestational age (SGA)
neonate after 34 weeks of pregnancy and who had a frozen
serum sample (stored at −18 °C) taken during the first half of
pregnancy. A total of 103 women were included. SGA was
defined as a birthweight below the 10th percentile. Thewomen
in the study group were electronically matched by year of
delivery in a ratio of 1:2 with 206 white nulliparous women
(control group) with a singleton pregnancy who delivered a
normal birth weight neonate after 34 weeks of gestation and
who also had a frozen serum sample taken during the first half of
pregnancy. Relevant congenital abnormalities were excluded.
A third group consisted of 131 white women who had been
admitted due to severe pre-eclampsia and had delivered
before 34 weeks of pregnancy between 1993 and 2005. All of
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the women included in group 3 had a laboratory examination
for thrombophilia between 3 and 6 months after delivery. In
this group, tests were assayed from frozen samples (before
2001) or directly after sampling (after 2001). Severe pre-
eclampsia was defined as a diastolic blood pressure of more
than 110 mm Hg and proteinuria of more than 0.3 g/24 hours
or the development of HELLP syndrome indicated by
hemolysis (haptoglobin b0.2% or lactate dehydrogenase
≥600 U/L), elevated liver enzymes (aspartate aminotrans-
ferase ≥70 U/L), and low platelets (b100×109/L).
All women were screened for tissue transglutaminase
antibodies (TgA) by an in-house enzyme-linked immunosorbent
assaywith guinea pig tissue transglutaminaseas substrate. Sera
with borderline or positive TgA were subsequently tested for
IgA antiendomysium (EmA) and IgA antihuman recombinant
tissue transglutaminase (Celikey; Pharmacia diagnostics, Frei-
burg, Germany). Patients were considered to have positive
celiac serology if both TgA and EmA were positive [2].
Sample size calculation was based on a prevalence of
asymptomatic celiac disease of 1% in the general population
[1]. A total of 100 cases and 200 controls would enable
detection of an odds ratio of 7 or larger for celiac disease in
women with pre-eclampsia or who delivered a small for
gestational age neonate with α=0.05 and β=0.2.
One woman in the SGA group and 1 woman in the severe
pre-eclampsia group tested positive for both TgA and EmA
(Table 1). Neither woman had gastrointestinal symptoms and
their hemoglobin levels were normal. None of the women in
the control group tested positive for TgA or EMA.
The present strategy of using TgA as a screening test and
EmA for confirmation of a positive serological test has a
sensitivity of 90.4% and a specificity of 99.7% when using
intestinal biopsy as gold standard for the diagnosis of celiac
disease [2]. Based on these test characteristics, we may have
underestimated the prevalence in our population by 9.6% of
the observed prevalence. With an observed prevalence of
1% at most, such underestimation is negligible. The high
specificity makes false positive results unlikely.
Three studies have assessed the incidence of low birth
weight in women diagnosed with celiac disease registered in
a national or regional health register and compared with the
remaining women. The incidence of SGA neonates was 6%–8%
in the cases and 2%–3% in the controls (OR, 1.6–3.4) [3–5].
The first two studies observed the higher incidence of SGA
only in untreated women; the third study did not observe a
difference between treated or untreated women.
Two studies have described the prevalence of women
with positive serological markers (TgA and EmA) in a cohort
of women who had SGA neonates, similar to our study [6,7].
These studies confirmed positive screening results by small
intestinal biopsy. The first study (39 SGA neonates) observed
a prevalence of 15% in women with an SGA neonate; the
second study (n=448) had a prevalence of 1.6%, which
was assumed to be 2 times higher than in the general
population.
Two cohort studies, based on regional disease classifica-
tion registers, observed a similar incidence of pre-eclampsia
in women with celiac disease as in a control group, although
power was insufficient to exclude small differences [5,8].
Combining our study and the study of Salvatore et al. [7],
the relative risk for celiac disease in women with an SGA
neonate may be approximately 2. This low relative risk and
the conflicting data regarding the effect of dietary treat-
ment on perinatal outcome suggest that serological screen-
ing for subclinical celiac disease before or at the beginning of
pregnancy is not indicated. Similarly, testing for asympto-
matic celiac disease is not indicated routinely in women after
delivery of an SGA neonate or after pre-eclampsia.
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Table 1 Demographic, perinatal, and celiac serology test
outcome data (anti TgA and anti EmA positive) for the three
study groups a




No. 103 131 206
Age, years 30.4±5.9 30.3±4.7 30.2±6.4
BMI 22.9±5.1 b 25.8±4.7 c 23.0±4.2
Smoking ≥1
cigarette/day




83±14 b 107±20 c 79±12
Gestational age,
weeks
39.1±1.9 b, c 30.0±2.4 c 40.0±1.6
Birth weight, g 2461±413 b, c 1015±352 c 3322±257







1.0 (0.0–5.1) 0.8 (0.0–3.2) 0.0 (0.0–0.9)
Abbreviations: SGA, small for gestational age neonate; BMI,
body mass index (calculated as weight in kilograms divided
by height in meters squared).
a Values are given as number (percentage) or mean±SD unless
otherwise indicated.
b Pb0.05 compared with the severe pre-eclampsia/HELLP
group.
c Pb0.05 compared with the control group.
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A rash occurring during pregnancy is a diagnostic challenge.
Rashes peculiar to pregnancy are pruritic urticarial papules
and plaques of pregnancy (PUPPP), prurigo of pregnancy,
pruritic folliculitis of pregnancy, and pemphigoid gestationis
[1,2]. Cryoglobulinemic vasculitis presents clinically with a
palpable pruritic rash and occasionally involves the internal
organs. Its early detection has diagnostic and therapeutic
significance [3].
A 21-year-old primigravida was hospitalized at 26 weeks of
pregnancy with a pruritic rash involving the lower extremities.
It was not associated with fever or malaise. There was no
history of cold sensitivity or cold-induced urticaria, allergy to
food or drugs, recent infection, autoimmune disorder, or
malignancy. Physical examination revealed a palpablemacular
rash involving both legs (Fig. 1). Initial laboratory investiga-
tions suggested mild leukocytosis and thrombocytosis, but
examination of peripheral blood smear revealed pseudoleu-
kocytosis and pseudothrombocytosis. Small irregular grayish-
blue extracellular precipitates were seen in the background.
Renal and liver profiles were normal. There were no anti-
nuclear, anti-double-stranded DNA (anti-dsDNA), antineutro-
phil, or anti-beta 2-glycoprotein I antibodies. Rheumatoid
factor was mildly elevated (titers 1:80). Perinuclear-staining
antineutrophil cytoplasmic antibodies (pANCA) and cytoplas-
mic-staining antineutrophil cytoplasmic antibodies (cANCA)
were absent. Complement component 3 (C3) was normal;
however, C4was reduced (0.19 g/L). Serologic tests for syphilis
and hepatitis B antibodies were negative. Third-generation
anti-HCV (hepatitis C virus) enzyme-linked immunosorbent
assay test containing synthetic peptide HCV antigens was also
negative.
Serum protein electrophoresis revealed M-spike; and further
analysis by immunofixationdetectedpolyclonal immunoglobulin
G (IgG) and monoclonal immunoglobulin M (IgM) kappa. Screen-
ing for cryoglobulins was positive. Skin biopsy from the leg
showed leukocytoclastic vasculitis (Fig. 2). An ultrasound
examination for fetal well-being was unremarkable.
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Figure 1 Essential mixed cryoglobulinemia: Macular rash on
legs.
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